No Data
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new p
Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co.
Krystal Biotech Price Target Maintained With a $200.00/Share by HC Wainwright & Co.
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the
Krystal Biotech Reveals Eye Treatment Vector at ARVO 2024
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
Krystal Biotech's Battle to Scale VYJUVEK Production Amid Regulatory Hurdles and Soaring Demand